UBS Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15,708
| Closed | -$1.37K | – | 9147 |
|
|
2023
Q3 | $1.37K | Buy |
15,708
+15,483
| +6,881% | +$1.35K | ﹤0.01% | 6819 |
|
|
2023
Q2 | $126 | Hold |
225
| – | – | ﹤0.01% | 7386 |
|
|
2023
Q1 | $257 | Sell |
225
-1,157
| -84% | -$1.32K | ﹤0.01% | 8011 |
|
|
2022
Q4 | $1.55K | Sell |
1,382
-10,012
| -88% | -$11.2K | ﹤0.01% | 8645 |
|
|
2022
Q3 | $23K | Buy |
11,394
+11,169
| +4,964% | +$22.5K | ﹤0.01% | 6137 |
|
|
2022
Q2 | $0 | Hold |
225
| – | – | ﹤0.01% | 10065 |
|
|
2022
Q1 | $0 | Sell |
225
-2,547
| -92% | – | ﹤0.01% | 9892 |
|
|
2021
Q4 | $3K | Sell |
2,772
-2,216
| -44% | -$2.4K | ﹤0.01% | 8599 |
|
|
2021
Q3 | $15K | Buy |
4,988
+3,289
| +194% | +$9.89K | ﹤0.01% | 6393 |
|
|
2021
Q2 | $5K | Buy |
+1,699
| New | +$5K | ﹤0.01% | 7489 |
|
|
2020
Q4 | – | Sell |
-600
| Closed | -$3K | – | 7756 |
|
|
2020
Q3 | $3K | Buy |
+600
| New | +$3K | ﹤0.01% | 6702 |
|
|
2020
Q1 | – | Sell |
-4,565
| Closed | -$32K | – | 7322 |
|
|
2019
Q4 | $32K | Sell |
4,565
-2,991
| -40% | -$21K | ﹤0.01% | 5547 |
|
|
2019
Q3 | $29K | Buy |
7,556
+6,087
| +414% | +$23.4K | ﹤0.01% | 5556 |
|
|
2019
Q2 | $6K | Buy |
+1,469
| New | +$6K | ﹤0.01% | 6462 |
|
|
2019
Q1 | – | Sell |
-3,602
| Closed | -$28K | – | 7216 |
|
|
2018
Q4 | $28K | Buy |
+3,602
| New | +$28K | ﹤0.01% | 5631 |
|